ADAR1 Capital Management »

Digital World Acquisition Co Class A shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Digital World Acquisition Co Class A (DJT) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Digital World Acquisition Co Class A

Tip: Access up to 7 years of quarterly data

All positions including Digital World Acquisition Co Class A held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Digital World Acquisition Co Class A by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $279k 4.5k 61.96

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Digital World Acquisition Co Class A

Susquehanna International
Citadel Advisors
Vanguard Group
Jane Street
BlackRock
Geode Capital Management
Capital Fund Management
State Street Corporation
Greenwich Wealth Management
Charles Schwab Investment Management
Gts Securities
Wolverine Trading
Bank Of Montreal
Goldman Sachs Group
Northern Trust

View all funds holding Digital World Acquisition Co Class A